Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index; 9 of the 125 sources its claims cite were checked for support.

Synthesis and Biological Application of Polylactic Acid

Open access

Abstract

Over the past few decades, with the development of science and technology, the field of biomedicine has rapidly developed, especially with respect to biomedical materials. Low toxicity and good biocompatibility have always been key targets in the development and application of biomedical materials. As a degradable and environmentally friendly polymer, polylactic acid, also known as polylactide, is favored by researchers and has been used as a commercial material in various studies. Lactic acid, as a synthetic raw material of polylactic acid, can only be obtained by sugar fermentation. Good biocompatibility and biodegradability have led it to be approved by the U.S. Food and Drug Administration (FDA) as a biomedical material. Polylactic acid has good physical properties, and its modification can optimize its properties to a certain extent. Polylactic acid blocks and blends play significant roles in drug delivery, implants, and tissue engineering to great effect. This article describes the synthesis of polylactic acid (PLA) and its raw materials, physical properties, degradation, modification, and applications in the field of biomedicine. It aims to contribute to the important knowledge and development of PLA in biomedical applications.

Overview

CoChat Summary

TL;DR

This review summarizes polylactic acid (PLA) synthesis, physical properties, degradation, modification, and biomedical applications. It highlights PLA’s biocompatibility and biodegradability while noting challenges in mechanical properties, nanoparticle drug-delivery commercialization, and production cost.

Key findings

  • PLA is a biodegradable, biocompatible polymer approved by the FDA for biomedical use; it is made from lactic acid, which is traditionally obtained by sugar fermentation, and exists as PLLA, PDLA, and PDLLA.
  • Key properties include processing temperatures of 170–230 °C; PLLA and PDLA melting points of 207 °C; racemic crystals with a melting point of 230 °C and ultimate tensile strength of 50 MPa; a glass transition temperature of 55 °C for PLA of 22,000 g mol−1; and a heat of fusion of 93.7 J g−1 for 100% pure crystals.
  • Modification by copolymerization, blending, plasticizers, or crosslinking can improve PLA’s hydrophobicity, toughness, and degradation; examples include PLA–PEG hemoglobin microcapsules reaching a 90% embedding rate versus 7.9% for PLA alone, a PLA–naltrexone complex with 67% in vitro release at 35 days, and PLA–PEG–PLA paclitaxel microspheres with 49% release in one month.
  • Biomedical applications include tissue engineering, drug delivery, and implants; PLA-based stents are commercialized, and 3D-printed PLA scaffolds are reported to cause less inflammation, but no PLA nanoparticle has been successfully marketed for drug delivery.

Methods

  • Narrative review of PLA synthesis, raw materials, physical properties, degradation, modification, and biomedical applications; no primary experimental data, sample, or systematic search strategy is described.
  • Main analysis is qualitative synthesis of cited literature and selected examples, with no meta-analysis or statistical pooling.

Limitations

  • The paper states that PLA suffers from brittleness, poor mechanical properties, slow crystallization speed, and low crystallinity; it also states that drug-delivery nanoparticles face challenges including side effects, toxicity, size/position/shape issues, positive-charge cytotoxicity, oxidative stress, DNA damage, ROS-related inflammation, hemolysis risk, complex disease microenvironments, and blood interactions, and that commercialization is limited by price and raw-material production efficiency.
  • Evident from the text: as a narrative review, it lacks systematic search/inclusion criteria and quantitative synthesis, and many claims rely on cited secondary literature without new experimental validation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/molecules25215023

Cites

140 of 140 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Enantiomers of lactic acid.
Figure 1 Enantiomers of lactic acid.CC BY · PubMed Central
Figure 2 Synthesis of polylactic acid (PLA) from l- and d-lactic acids [28]. Adapted from Auras et al. by permission of Wiley–VCH Verlag GmbH & Co. KGaA.
Figure 2 Synthesis of polylactic acid (PLA) from l- and d-lactic acids [28]. Adapted from Auras et al. by permission of Wiley–VCH Verlag GmbH & Co. KGaA.CC BY · PubMed Central
Figure 3 Stereoforms of lactides.
Figure 3 Stereoforms of lactides.CC BY · PubMed Central
Figure 4 High drug loading and pH-responsivity PLA-g-doxorubicin (DOX) nanoparticles [99]. Reprinted from Cheng with permission from Express Polymer Letters.
Figure 4 High drug loading and pH-responsivity PLA-g-doxorubicin (DOX) nanoparticles [99]. Reprinted from Cheng with permission from Express Polymer Letters.CC BY · PubMed Central
Figure 5 Schematic illustration of the concept of stereocomplex hydrogel formed by mixing aqueous solutions of bio-polymers containing enantiomeric oligo(lactic acid) [125]. Reprinted from Nostrum with permission from Express Polymer Letters.
Figure 5 Schematic illustration of the concept of stereocomplex hydrogel formed by mixing aqueous solutions of bio-polymers containing enantiomeric oligo(lactic acid) [125]. Reprinted from Nostrum with permission from Express Polymer Letters.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 64 Not checked · 10 Own results and interpretations

31 more claims

Create a free account to see all 78 claims and to verify the 116 references still open.

See all claims — free account
  • It may state two separate claims as one. 25
  • Probably not a substantial claim. 22

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 140 references

Research works printed but not linked: 1

  1. Bud, 1993, A history of lactic-acid making–A chapter in the history of biotechnology-benninga,h, Ann. Sci., 50, 597

Cited by

See all 492

Metadata

Authors
Li, G., Zhao, M., Xu, F., Yang, B., Li, X., Meng, X., Teng, L., Sun, F., & Li, Y.
Affiliations
Jilin University (CN)
Corresponding author
  • Sun, Fengying
  • Li, Youxin
Venue
Molecules
Publisher
MDPI AG
Published
2020-10-29
Volume
25
Issue
21
Pages
5023
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3096086014
Cited by
492
References
140
Citations by year
2026: 55 · 2025: 115 · 2024: 112 · 2023: 105 · 2022: 71 · 2021: 34
FWCI
3.52
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
People's Government of Jilin Province (20180101269JC)
Topics
  • Physical Sciences › Materials Science › Biomaterials › biodegradable polymer synthesis and properties
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Surgery › Surgical Sutures and Adhesives
Keywords
polylactic acid, lactic acid, biodegradable polymers, biocompatibility, polymer synthesis, polymer modification, drug delivery, implants, tissue engineering, biodegradation, sugar fermentation
MeSH terms
Biocompatible Materials, Humans, Polyesters, Drug Delivery Systems, Prostheses and Implants, Tissue Engineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synthesis and Biological Application of Polylactic Acid. https://app.cochat.ai/papers/10.3390/molecules25215023
The paper
Li, G., Zhao, M., Xu, F., Yang, B., Li, X., Meng, X., Teng, L., Sun, F., & Li, Y. (2020). Synthesis and Biological Application of Polylactic Acid. Molecules. https://doi.org/10.3390/molecules25215023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.